A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.
A proposed bill would require cannabis products to carry large warnings, similar to cigarettes. But the state's legal pot industry says more rules make it harder to compete with the illicit market.
